References
- Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, Gritti D, Herold M, Wiedermann CJ. (2001). Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 25:97–100.
- Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, Olsson NO, Blettery B. (2008). Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 8:38.
- Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA. (2004). A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291:2727–33.
- Hoffmann G, Totzke G, Seibel M, Smolny M, Wiedermann FJ, Schobersberger W. (2001). In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med 29:112–16.
- Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P, Cokkinos DV. (2008). Procalcitonin in acute myocardial infarction. Acute Card Care 10:30–6.
- Katori T, Hoover DB, Ardell JL, Helm RH, Belardi DF, Tocchetti CG, Forfia PR, Kass DA, Paolocci N. (2005). Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Circ Res 96:234–43.
- Martinez JM, Wagner KE, Snider RH, Nylen ES, Muller B, Sarani B, Becker KL, White JC. (2001). Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surg Infect (Larchmt) 2:193–202; discussion 202-3
- Maruna P, Nedelnikova K, Gurlich R. (2000). Physiology and genetics of procalcitonin. Physiol Res 49 (Suppl. 1):S57–61.
- Morgenthaler NG, Struck J, Fischer-Schulz C, Bergmann A. (2002). Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem 48:788–90.
- Nijsten MW, Hoekstra OP. (2001). In vitro and in vivo stimulation of procalcitonin by TNF alpha and IL-6. J Anasthesie Intensivtherapie 2:58–60.
- Remskar M, Horvat M, Hojker S, Noc M. (2002). Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114:205–10.
- Schuetz P, Mueller B, Trampuz A. (2007). Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 35:352–5.
- Senturk T, Cordan J, Baran I, Ozdemir B, Gullulu S, Aydinlar A, Goral G. (2007), Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 62:135–41.
- Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. (2006). Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 10:R145.